Asthma and COPD Health Expenditures Considerable in US Workers
Among the estimated 166 million US workers, 8 and 7 million had at least 1 asthma-related and at least 1 COPD-related medical event, respectively, between 2011 and 2015.
Practice Management
USPSTF Advises Annual Low-Dose CT Lung Screening for High-Risk Individuals
Annual CT screening recommended for patients aged 50 to 80 years at high risk for lung cancer from smoking.
FDA: Risk of Methanol Toxicity With Certain Hand Sanitizers
Hand sanitizers containing methanol, or wood alcohol, present a danger to individuals as the substance can be toxic when absorbed through the skin or life-threatening if ingested.
CDC Issues Guidance on Vaccination During the COVID-19 Pandemic
Routine vaccination should not be delayed due to the COVID-19 pandemic, according to interim guidance released by the Centers for Disease Control and Prevention.
Physican Resident Errors Increase When Extended ICU Shifts Are Reduced
Researchers compared 2 schedules for pediatric resident physicians during their ICU rotations: extended-duration work schedules and schedules that eliminated extended shifts.
COVID-19 Drug Remdesivir May Cost More Than $3000 Per Patient
In the United States, government programs and additional Gilead assistance should mean all patients have access to remdesivir.
High Rates of Inappropriate Antibiotic Prescribing for Acute Sinusitis in Primary Care
A study revealed that primary care clinicians do not closely follow clinical practice guidelines with regard to antibiotic prescribing for acute sinusitis and frequently overprescribe antibiotics.
ACP: US Response to COVID-19 Identifies Inequalities in Health Care System
The American College of Physicians statement outlines how the “status quo” created health inequalities and prevented the spread of the COVID-19 virus, and outlines steps on how to move forward.
COVID-19 Incidence in Nursing Homes Linked to RN Staffing
An increase in registered nurse staffing was linked to reductions in confirmed cases and fewer COVID-19 deaths.
Costs Associated With 4 Months of Rifampin vs 9 Months of Isoniazid in Latent TB
Health system use and costs higher for 9 months of isoniazid vs 4 months of rifampin in adults and children in all settings.
-
Loading...
-
Loading...
Next post in Tuberculosis
